
Our latest news for ‘NASH’
We are proud to be leading the way in providing more patient-centric solutions for people with liver disease that helps them and their physician make informed decisions about their care.
Read our latest news to find out more about how we are helping to improve the understanding of liver disease.


New non-invasive MRI biomarker for liver disease could cut costs for drug trials
Posted: September 22, 2020

First European guidance on the use of multiparametric MRI in fatty liver disease
Posted: September 4, 2020

Multiparametric MRI: bridging the diagnostic gap for liver disease
Posted: August 7, 2020



Going Beyond the Biopsy & Adopting Noninvasive Technologies
Posted: June 8, 2020

